Scienture Holdings, Inc. Common Stock
Market Cap
16M
Short interest (May 15)
2.8%
Net Short (Jun 03 ): -0.1%
Borrow Fee
16.77%
↓ 5.3%
Available Shares
1M
↑ 21.3%
Price Chart
Company Overview
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.